Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013

NCT01747369

Last updated date
Study Location
Centre Hospitalier Régional (CHR) Savanes
Dapaong, Savanes region, , Togo
Contact
+228-921 29 31

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

By phone

Pfizer Clinical Trials Contact Center

+228-921 29 31

By email

Contact

[email protected]

Call Now

Eligibility Criteria
condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Bacterial Pneumonia, Viral Pneumonia, Bacterial Meningitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion Criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- resident of Tône sanitary district - requiring hospitalisation for at least one night for clinical pneumonia syndrome

- hospitalised in a study site during the study period

Exclusion Criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details


- absence of informed consent by patient or legal tutor

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

TRY A NEW SEARCH

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Bacterial Pneumonia, Viral Pneumonia, Bacterial MeningitisSurveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
NCT01747369
  1. Dapaong, Savanes region
  2. Dapaong, Savanes region
  3. Dapaong, Savanes region
  4. Dapaong, Savanes region
ALL GENDERS
0+
years
MULTIPLE SITES
Advanced Information
Descriptive Information
Brief Title Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Official Title Not Provided
Brief Summary The aim of this study is to estimate the burden of disease due to pneumococci, other bacteria and viruses in the African meningitis belt prior to pneumococcal conjugate vaccine introduction and to estimate the population impact of the vaccine after its implementation in 2014. In a defined population of a sanitary district in northern Togo, during the period 2010 to 2017, investigators enroll patients of all ages with suspected pneumonia requiring hospitalization or suspected bacterial meningitis. Patients are evaluated by bacteriology and molecular biology techniques on blood, cerebro-spinal fluid, nasal aspirates and by chest X-ray.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples With DNA
Description:
Whole blood, cerebro-spinal fluid, nasal aspirate
Sampling Method Non-Probability Sample
Study Population

Pneumonia surveillance:

-residents of Tône sanitary district requiring hospitaliation for suspected pneumonia and presenting at one of the hospitals of Dapaong town (district capital)

Meningitis surveillance:

- residents fo Tône sanitary district presenting with suspected meningitis at one of the hospitals of Dapaong town (district capital) or Sinkasse health center

Condition
  • Pneumonia, Bacterial
  • Pneumonia, Viral
  • Meningitis, Bacterial
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: December 10, 2012)
2000
Original Estimated Enrollment Same as current
Estimated Study Completion Date June 2017
Estimated Primary Completion Date June 2017   (Final data collection date for primary outcome measure)
Eligibility Criteria

Pneumonia surveillance:

Inclusion Criteria:

  • resident of Tône sanitary district - requiring hospitalisation for at least one night for clinical pneumonia syndrome
  • hospitalised in a study site during the study period

Exclusion Criteria:

  • absence of informed consent by patient or legal tutor

Meningitis surveillance:

Inclusion Criteria:

  • resident of Tône sanitary district
  • presenting clinical signs of acute bacterial meningitis
  • hospitalised in a study site during the study period

Exclusion Criteria:

  • absence of informed consent by patient or legal tutor
Sex/Gender
Sexes Eligible for Study:All
Ages Child, Adult, Older Adult
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Togo
Removed Location Countries  
 
Administrative Information
NCT Number NCT01747369
Other Study ID Numbers PneumoTone
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Agence de Médecine Préventive, France
Study Sponsor Agence de Médecine Préventive, France
Collaborators
  • Region Sanitaire des Savanes, Togo
  • Ministere de la Sante et de la Promotion Sociale, Togo
  • Institut National d'Hygiene, Togo
  • Centre Muraz
  • Fondation Mérieux, France
  • Pfizer
Investigators
Principal Investigator:Jennifer C Moïsi, PhDAgence de Médecine Préventive
PRS Account Agence de Médecine Préventive, France
Verification Date March 2017